1. Technical advantages
The company is a national high-tech enterprise. It has 23 utility model patents. Through technological innovation, it has high competitive advantages in product yield, production cost and energy consumption, forming the enterprise's technological innovation system and core competitiveness.
2. Scale advantage
With an annual output of 200 tons of p-acetylaminobenzoic acid, 30 tons of 3,4-dihydroxybenzonitrile, 30 tons of 6-chloro-3-methyluracil, 30 tons of N, n-diethylcyanoacetamide, 30 tons of 3,4-dihydroxy-5-nitrobenzaldehyde and other pharmaceutical intermediates, it provides a strong guarantee for the continuous supply of the company.
3. Market advantages
The company has extensive contacts and business contacts with some well-known pharmaceutical manufacturers in the world. Its products are mainly exported to Europe, America and Asia, such as Germany, France, Japan, Italy, India and so on.
4. Quality management advantages
It has passed iso9001:2015 quality management system certification.
The integrated quality control process of raw materials, processes and products has been established to ensure the stability and reliability of product quality, and the product quality can meet the production needs of foreign manufacturers.
5. Service advantages
The company always pursues the service tenet of "quality first and customer satisfaction", and always pursues the policy of "performing the contract according to quality, quantity and time".